Millennium Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $142M | Sell |
|
|||||
|
2025
Q2 | $156M | Buy |
|
|||||
|
2025
Q1 | $47.7M | Buy |
|
|||||
|
2024
Q4 | $26.8M | Sell |
|
|||||
|
2024
Q3 | $45.2M | Sell |
|
|||||
|
2024
Q2 | $92.1M | Sell |
|
|||||
|
2024
Q1 | $199M | Buy |
|
|||||
|
2023
Q4 | $113M | Buy |
|
|||||
|
2023
Q3 | $23.4M | Sell |
|
|||||
|
2023
Q2 | $28.6M | Buy |
|
|||||
|
2023
Q1 | $32.1M | Sell |
|
|||||
|
2022
Q4 | $81.3M | Sell |
|
|||||
|
2022
Q3 | $159M | Buy |
|
|||||
|
2022
Q2 | $126M | Buy |
|
|||||
|
2022
Q1 | $100M | Buy |
|
|||||
|
2021
Q4 | $62.6M | Sell |
|
|||||
|
2021
Q3 | $65.6M | Buy |
|
|||||
|
2021
Q2 | $3.42M | Sell |
|
|||||
|
2021
Q1 | $18.5M | Sell |
|
|||||
|
2020
Q4 | $41.3M | Sell |
|
|||||
|
2020
Q3 | $38.7K | Buy |
|
|||||
|
2020
Q2 | $16.6M | Sell |
|
|||||
|
2020
Q1 | $19.3M | Sell |
|
|||||
|
2019
Q4 | $51.6M | Buy |
|
|||||
|
2019
Q3 | $17M | Sell |
|
|||||
|
2019
Q2 | $35.2M | Buy |
|
|||||
|
2019
Q1 | $15.5M | Buy |
|
|||||
|
2018
Q4 | $9.05M | Sell |
|
|||||
|
2018
Q3 | $32.5M | Sell |
|
|||||
|
2018
Q2 | $55.5M | Sell |
|
|||||
|
2018
Q1 | $52.3M | Buy |
|
|||||
|
2017
Q4 | $56.6M | Buy |
|
|||||
|
2017
Q3 | $44.2M | Sell |
|
|||||
|
2017
Q2 | $80.4M | Buy |
|
|||||
|
2017
Q1 | $261K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $31.2M | Buy |
|
|||||
|
2016
Q2 | $4.8M | Sell |
|
|||||
|
2016
Q1 | $14.2M | Sell |
|
|||||
|
2015
Q4 | $99.5M | Buy |
|
|||||
|
2015
Q3 | $77M | Sell |
|
|||||
|
2015
Q2 | $142M | Sell |
|
|||||
|
2015
Q1 | $149M | Buy |
|
|||||
|
2014
Q4 | $82.8M | Buy |
|
|||||
|
2014
Q3 | $49.6M | Sell |
|
|||||
|
2014
Q2 | $86.4M | Buy |
|
|||||
|
2014
Q1 | $2.2M | Sell |
|
|||||
|
2013
Q4 | $66.7M | Buy |
|
|||||
|
2013
Q3 | $3.96M | Sell |
|
|||||
|
2013
Q2 | $13.3M | Buy |
|